In this episode of the Live Yes! With Arthritis podcast, we revisit the top takeaways from some of 2024’s most popular and intriguing episodes. Guests and hosts share what most resonated with them ...

Celebrating with food and drinks is one of the joys of the holiday season, but that can be a problem for many people living with arthritis. Weight gain, preparing a feast when you have sore joints, ...

Learn more about the risks of having total knee replacement surgery too soon and what researchers have learned from the rise in revision surgeries. As more and more Americans choose to have total knee ...

Learn about the federal laws that protect the educational rights of your child with arthritis. Children with juvenile arthritis (JA) requiring special education or physical accommodations from their ...

A good doctor-patient relationship is built on trust. You understand and respect your doctor’s point of view. Your doctor, in turn, understands and respects yours. A successful partnership takes time ...

Get more information about how getting social support from a formal group or a circle of friends, can help you cope with PsA. Medical management is only one part of treating psoriatic arthritis (PsA).

Find out which foods to eat and which to avoid if you have gout. Question: I have gout. Can you tell me which fruits, vegetables, meats or seafoods I should eat — or avoid? Is there any type of ...

These pain relief methods include creams, exercise, CAM therapies, footwear, nerve treatments and injections. According to the National Center for Health Statistics, 76.2 million, or 26% of Americans, ...

Learn about the four most common warning signs of arthritis. How do you know if your joint symptoms mean you have arthritis? Only a health care professional can tell you for sure, but certain signs ...

Learn why you may need to stop taking certain supplements like glucosamine, chondroitin and others before you have surgery. If you have surgery scheduled soon, you may need to set aside your ...

The U.S. Food and Drug Administration (FDA) has approved Renflexis (infliximab-abda), a biosimilar to Remicade (infliximab), making it the fourth biosimilar approved to treat inflammatory types of ...